Exact Sciences
EXAS
#1179
Rank
A$27.91 B
Marketcap
A$146.96
Share price
0.04%
Change (1 day)
61.10%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2025 (TTM): A-$8.54

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is A-$7.64. In 2024 the company made an earnings per share (EPS) of A-$8.00.

EPS history for Exact Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$8.546.77%
2024A-$8.00
2022A-$5.082.31%
2021A-$4.97-38.54%
2020A-$8.08692.96%
2019A-$1.02-50.69%
2018A-$2.0744%
2017A-$1.44-39.39%
2016A-$2.37-2.94%
2015A-$2.4437.1%
2014A-$1.7879.71%
2013A-$0.99-21.59%
2012A-$1.26

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
A$5.32-169.66%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
A$0.56-107.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
A$0.49-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
A-$6.22-18.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
A-$73.09 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA